UnitedHealth (UNH) reported Q3 FY2024 earnings of $7.15 per share (versus $6.56 per share in Q3 FY2023), beating analysts’ consensus estimate of $7.00 per share.
The company’s quarterly revenues amounted to $100.820 bln (+9.2% y/y), beating analysts’ consensus estimate of $99.139 bln.
The company also issued in-line EPS guidance for FY2024 of $27.50-27.75 versus analysts’ consensus estimate of $27.69.
UNH fell to $588.00 (-2.87%) in pre-market trading.